News

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the beverages, alcohol, and tobacco stocks, including Coca-Cola (NYSE:KO) and its peers.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services (NYSE:AMN) and its peers.

Let’s dig into the relative performance of agilon health (NYSE:AGL) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at vertical software stocks, starting with Manhattan Associates (NASDAQ:MANH).

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the home builders industry, including Meritage Homes (NYSE:MTH) and its peers.

Let’s dig into the relative performance of Petco (NASDAQ:WOOF) and its peers as we unravel the now-completed Q4 specialty retail earnings season.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the professional staffing & hr solutions industry, including Robert Half (NYSE:RHI) and its peers.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the renewable energy industry, including Blink Charging (NASDAQ:BLNK) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at sit-down dining stocks, starting with Bloomin' Brands (NASDAQ:BLMN).

Haemonetics has gotten torched over the last six months - since October 2024, its stock price has dropped 20.1% to $63.39 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.